chr8-11994113-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001302695.2(DEFB134):c.68C>T(p.Ser23Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000825 in 1,611,190 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001302695.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEFB134 | NM_001302695.2 | c.68C>T | p.Ser23Leu | missense_variant | 3/3 | ENST00000382205.6 | NP_001289624.1 | |
DEFB134 | XM_017013724.1 | c.68C>T | p.Ser23Leu | missense_variant | 3/3 | XP_016869213.1 | ||
DEFB134 | XM_047422075.1 | c.68C>T | p.Ser23Leu | missense_variant | 2/2 | XP_047278031.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEFB134 | ENST00000382205.6 | c.68C>T | p.Ser23Leu | missense_variant | 3/3 | 1 | NM_001302695.2 | ENSP00000371640.4 | ||
DEFB134 | ENST00000526438.6 | c.68C>T | p.Ser23Leu | missense_variant | 2/2 | 1 | ENSP00000435010.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152146Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000165 AC: 41AN: 248076Hom.: 0 AF XY: 0.000261 AC XY: 35AN XY: 134110
GnomAD4 exome AF: 0.0000884 AC: 129AN: 1458926Hom.: 2 Cov.: 30 AF XY: 0.000138 AC XY: 100AN XY: 725686
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152264Hom.: 1 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 17, 2023 | The c.68C>T (p.S23L) alteration is located in exon 2 (coding exon 2) of the DEFB134 gene. This alteration results from a C to T substitution at nucleotide position 68, causing the serine (S) at amino acid position 23 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at